Navigation Links
HDSA Applauds Announcement of the First Therapy to be Approved for the Specific Treatment of a Symptom of Huntington's Disease
Date:8/15/2008

NEW YORK, Aug. 15 /PRNewswire/ -- The approval of Xenazine(R) (tetrabenazine), for the treatment of chorea associated with Huntington's Disease (HD), the first therapy to be approved specifically for the disease, is a significant milestone for all of our patients, families and caregivers in the HD community. Huntington's Disease Society of America (HDSA) is very pleased that we have the first treatment to alleviate one of the symptoms of this devastating disease.

"This is a great moment for our families, who have been waiting for answers to HD for a long time," said Barbara Boyle, National Executive Director/CEO of HDSA. "Our families should be proud that their advocacy efforts helped make a difference. We thank the developers of Xenazine for their work and perseverance, and look forward to more announcements of therapeutic approvals by the FDA in the near future. We will provide information on the future availability of Xenazine on our website (http://www.hdsa.org), and in our electronic and print publications as soon as details are provided to HDSA."

Huntington's Disease is a devastating, hereditary, degenerative brain disorder for which there is, at present, no effective treatment or cure. HD slowly diminishes the affected individual's ability to walk, think, talk and reason. Eventually, the person with HD becomes totally dependent upon others for his or her care. Huntington's Disease profoundly affects the lives of entire families -- emotionally, socially and economically. More than a quarter of a million Americans have HD or are "at risk" of inheriting the disease from an affected parent. HD affects as many people as Hemophilia, Cystic Fibrosis or ALS.

Early symptoms of Huntington's Disease may affect cognitive ability or mobility and include depression, mood swings, forgetfulness, clumsiness, involuntary twitching and lack of coordination. As the disease progresses, concentration and s
'/>"/>

SOURCE Huntington's Disease Society of America
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. AIDS Action Committee Applauds Legislature for Taking Action to Protect Patient Privacy Within New Electronic Medical Records System
2. AMA Applauds U.S. House for Acting to Protect Americans From the Dangers of Tobacco
3. CMMB Applauds America at Its Best as PEPFAR is Reauthorized by U.S. Government
4. AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs
5. APHA Applauds Congressional Override of Medicare Veto
6. American Optometric Association Applauds Override of Medicare Cuts
7. ACP applauds Senate to vote to pass H.R. 6331 and avert physician payment cut
8. American Life League Applauds Congressional Action Against Planned Parenthood
9. NCOA Applauds Senate Passage of Medicare Bill
10. Kidney Community Applauds Senate for Passage of End Stage Renal Disease (ESRD) Improvements
11. Tubbs Jones Applauds Senate Passage of Medicare Improvements Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale ... announced price reductions on their popular PhenObestin 37.5 non-prescription ... clients to lose weight as effortlessly as possible has ... more than 50%. , Bottles have been reduced from ... all orders will receive free shipping. , Made ...
(Date:5/24/2013)... May 24, 2013 Today, Zane ... Indiana Health Insurance Exchange . Zane Benefits, ... employer sponsored health benefits, is the leader in ... reimbursement arrangements . , According to Zane Benefits’ ... Affordable Care Act (ACA), health insurance coverage for ...
(Date:5/24/2013)... 2013 DePuy ASR lawsuit ... to move forward in courts throughout the country, Bernstein ... California’s San Francisco Superior Court on April 25th, a ... her DePuy hip lawsuit is voluntarily seeking dismissal of ... al., No. CGC11508806; Calif. Super. Ct., San Francisco). , ...
(Date:5/24/2013)... Pomona, Calif. (PRWEB) May 24, 2013 ... has retained its status of “Full Accreditation” for the ... (AVMA) Council on Education (COE). , “This is a ... of our hard work and student outcomes,” said College ... want to express my appreciation to the faculty, staff, ...
(Date:5/24/2013)... 2013 With Memorial Day Weekend upon us, ... is offering tips to help prevent grill fires throughout ... Association (NFPA) reports that gas grills led to an ... or other solid-fueled grills, meanwhile, caused approximately 1,200 home fires ... Amica Insurance is sharing the following tips from the NFPA ...
Breaking Medicine News(10 mins):Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 3Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 4Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2
... June 25 Former U.S. Secretary of State Colin ... than 15,000 Lions volunteers from around the world and call ... these difficult economic times. , , (Logo: ... will deliver the keynote address on the importance and value ...
... 25 Futurist and world-recognized authority on technology trends ... Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) by ... of care, not the price of technology. , ... to an ambulatory surgical center (ASC) has reduced costs ...
... help determine "who owns who" in the world of multi-level marketing. ... suit in state court in Volusia County, Florida, today, "The last ... All we wanted to do was build businesses and help others ... Univera leaders Marshall Douglas and Joe Land, are former distributors of ...
... PF Week Sept. 14 - 21 , , ... (CPF) announced today it has scheduled its 2009 National Pulmonary Fibrosis ... of this year,s activity are to ensure passage of the PFREA, ... in communities nationwide. , , Specifically, the CPF is asking ...
... Late diagnosis costs lives that could be saved with powerful ... Too many Americans with HIV are diagnosed late in the ... benefit of effective treatments, U.S. health officials reported Thursday. , ... but up to a third don,t know they have the ...
... S.D., June 25 The ,Help is Here Express, bus ... of June 29 - July 3 at various cities in ... on programs that provide prescription medicines for free or nearly ... compared to 2.9 percent a year ago, the Partnership for ...
Cached Medicine News:Health News:Colin Powell Applauds Lions for Leadership in Volunteerism as Interest in Volunteer Service Grows 2Health News:Technological Advancements Shift Site-of-Care From the Operating Room to Your Doctor's Office 2Health News:Former Associates File Suit Against Univera: Dietary Supplement Company Accused of Intimidation, Bullying, and Unfair Trade Practices 2Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 2Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 3Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 4Health News:Too Few Americans Get HIV Test Early Enough 2Health News:Too Few Americans Get HIV Test Early Enough 3Health News:Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 4
(Date:5/23/2013)... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Executive Officer of Neurocrine Biosciences, will be presenting at the ... in Boston.   The live presentation takes place ... 8:20 a.m. Pacific Time.  The presentation will be webcast and ... . If you are unable to attend ...
(Date:5/23/2013)... , May 23, 2013 Hearing health affects ... feel younger, and remain socially and professionally engaged, he should ... the overriding message that the Better Hearing Institute ... of National Men,s Health Week , which leads up ... Week runs from June 10 through June 16. ...
(Date:5/23/2013)...  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), ... on intellectual property developed and owned by Hadassah ... medical research center, today announced that its portfolio ... from the Israeli Ministry of Industry and Commerce, ... product development and advance clinical trials. Cell Cure,s ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... include evaluation of safety and tolerability, ... Phase 2 trials -, ROCKVILLE, Md., May 30 ... announced that it has initiated dosing in a Phase,1 ... its lead IAP,inhibitor, HGS1029, as monotherapy in patients with ...
... Correlated With Clinical Response, CHICAGO, May ... today highlighted the potential of its,investigational MAGE-A3 ... studies evaluating highly targeted immunotherapy,as a treatment ... cancer,(NSCLC). These data were presented at the ...
Cached Medicine Technology:Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 2Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 3Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 4New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 2New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 3New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 4New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 5New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 6New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 7
... Biosense Webster offers a complete line ... in the atrium. The ISMUS CATH ... simple placement in the atrial isthmus. ... the catheter's distal tip permit pacing ...
... Biosense Webster is the source for ... catheters for left-sided mapping - all with ... come to expect from the leader in ... catheters are specifically designed and constructed to ...
... Inquiry H Steerable Catheter. ... a variety of designs and ... catheter stability. 10 to 24 ... curves, inactive and active tip ...
A steerable diagnostic catheter with optimal maneuverability...
Medicine Products: